U.S. Personal Products Stock News

Stock performance snapshot Verra Mobility (VRRM) has been under pressure, with the stock down about 0.7% over the past day and roughly 0.8% year to date, while the past year and past 3 months also reflect sizeable declines. At a recent close of US$3.85 and a market cap of about US$2.0b, the company sits against a backdrop of reported annual revenue of US$979.39m and net income of US$131.04m across its three core segments. See our latest analysis for Verra Mobility. The recent share price...

Diamond Hill Capital has initiated a new position in Carrier Global (NYSE:CARR), focusing on the company's resilience and operational strengths. The investment highlights expectations for market share gains and margin improvement opportunities, despite current pressure in residential markets. The move adds another institutional holder to Carrier Global's shareholder base at a share price of $64.51. For you as an investor, this fresh interest in NYSE:CARR comes as the stock trades around...

Earlier in May 2026, Duos Technologies Group, Inc. reported first-quarter 2026 results showing revenue of US$2.72 million, a widening net loss of US$3.49 million, and then reaffirmed its expectation for full-year 2026 revenue to exceed US$50 million while also planning a presentation at the Craig-Hallum 23rd Annual Institutional Investor Conference in Minneapolis on May 28, 2026. This combination of weaker quarterly performance, reiterated full-year revenue ambitions, and outreach to...

If you are wondering whether Avis Budget Group's share price still offers value after past gains or if most of the upside is already reflected, this article walks through what the current valuation might be telling you. The stock last closed at US$165.10, with returns of 8.0% over the past week, down 11.7% over the past month, up 28.8% year to date, and up 37.0% over the last year. Recent share price moves have kept investor attention on how the market is pricing in Avis Budget Group's...

Synopsys (NasdaqGS:SNPS) has appointed Jesse Cohn, a partner at Elliott Management, to its Board of Directors. The appointment comes as part of a new cooperation agreement between Synopsys and Elliott Management that includes board representation and voting commitments. This is the first major corporate governance adjustment at Synopsys in recent periods that brings an activist investor directly into the boardroom. Synopsys enters this governance shift with its shares at $525.92 and multi...

Helix Partners Management LP has fully exited its stake in Cinemark Holdings (NYSE:CNK), according to recent SEC filings. The move removes one institutional investor from Cinemark’s shareholder base and may influence how some investors view the stock. Cinemark operates movie theatres, giving it direct exposure to box office trends, content release schedules, and changing consumer habits. The exit by Helix comes at a time when the theatre industry continues to adjust to streaming...

Nexa Resources (NYSE:NEXA) has proposed amendments to its Articles of Association. Shareholders are scheduled to vote on the changes at the 2026 Annual General Meeting and Extraordinary General Meeting on June 25, 2026. The proposed amendments relate to core governance rules that can affect shareholder rights and future corporate decisions. Nexa Resources, trading at $14.51, has seen its share price rise 65.1% year to date and 196.9% over the past year, with a 194.5% return over three...

In May 2026, Monte Rosa Therapeutics reported encouraging Phase 1/2 data for MRT-2359 in metastatic castration-resistant prostate cancer and shared new preclinical findings for MRT-55811 showing tumor regression across several cancer models. At the same time, director Anthony M. Manning exercised options and sold US$180,100 of stock, a routine move that contrasts with the company’s recent scientific progress. Next, we’ll examine how these early-stage oncology results, especially the...

Box (BOX) opened Q1 2027 with total revenue of US$305.9 million and basic EPS of US$0.09 on net income of US$11.9 million, setting a measured tone for the new fiscal year. Over the past five reported quarters, revenue has moved from US$276.3 million in Q1 2026 to US$305.9 million in Q1 2027, while basic EPS has ranged from US$0.02 to US$0.48, giving investors a clear view of how the top line and per share earnings have tracked through recent periods. With trailing net profit margins below...

Ooma (OOMA) has kicked off Q1 2027 with revenue of about US$81.1 million and basic EPS of roughly US$0.09, alongside net income of around US$2.6 million. This sets a clear earnings tone for the new fiscal year. The company has seen quarterly revenue move from about US$65.0 million and a small net loss in Q1 2026 to roughly US$81.1 million and a net profit of around US$2.6 million in Q1 2027. Trailing twelve month EPS sits at about US$0.33 on revenue of roughly US$289.7 million, so the latest...

Agora (API) has reported Q1 2026 revenue of US$37.7 million and net income of US$1.1 million, equal to basic EPS of US$0.01, which follows a year where trailing twelve month revenue reached US$145.5 million and EPS came in at US$0.11. Over recent quarters the company has seen revenue move from US$33.3 million in Q1 2025 to US$38.2 million in Q4 2025 and EPS shift from US$0.00 to US$0.05 over the same period, providing a clearer view of how both top line and per share profitability have been...

Q32 Bio Inc. recently entered into a securities purchase agreement to raise US$55,000,000 through a private placement of 6,725,000 common shares at US$8.00 each and pre-funded warrants for 150,000 shares at US$7.9999, with closing expected on May 28, 2026, subject to customary conditions. The round is led by BVF Partners L.P. with participation from RA Capital Management, OrbiMed, and Atlas Venture, highlighting strong institutional interest in funding Q32 Bio’s development plans. Next,...

Recent performance and business snapshot Pony AI (PONY) has drawn investor attention after a period where the stock rose 4.3% over the past day and 11.4% over the past week, while declining over the month and past 3 months. At a last close of US$9.74 and a market cap of about US$4.0b, the company is generating revenue of US$110.27m while reporting a net loss of US$141.39m. Reported annual revenue growth of 43.7% sits alongside net income growth of 25.7%. This helps frame how this autonomous...

Ellomay Capital (NYSEAM:ELLO) opened 2026 with Q1 revenue of €8.7 million and a loss of €10.7 million in net income, which translated into basic EPS of a €0.78 loss, while trailing 12 month revenue stood at €42.6 million with a €19.7 million net loss and a basic EPS loss of €1.46. Over recent quarters, revenue has moved within a relatively tight band from €8.7 million to €11.3 million, while quarterly EPS has swung between a €0.85 loss and a €0.53 profit, underscoring how earnings are still...

Sociedad Química y Minera de Chile (NYSE:SQM) opened 2026 with Q1 revenue of about US$1.8 billion and basic EPS of US$1.28, setting a clear marker for how the year is starting. Over recent quarters, the company has seen revenue move from US$1,073.8 million in Q4 2024 to US$1,036.6 million in Q1 2025, then to US$1,760.0 million in Q1 2026. Over the same period, quarterly basic EPS shifted from US$0.42 to US$0.48 and then to US$1.28, giving investors a concrete view of how the top and bottom...

Forgent Power Solutions (NYSE:FPS) has launched a major follow on equity offering, aiming to raise fresh capital for the business. The company has also repriced its senior credit facilities, which is expected to materially reduce annual interest expenses. Together, these moves mark a clear shift in Forgent Power Solutions capital structure and financial flexibility. Forgent Power Solutions comes into this financing reset with the stock at $47.3 and strong recent momentum, up 5.7% over the...

Webco Industries (OTCPK:WEBC) has put up a punchy Q3 2026 print, with revenue of US$179.6 million, basic EPS of US$12.28 and trailing 12 month EPS of US$30.18 helping to lift trailing net profit margin to 3.1% from 1.2% a year earlier and earnings up 177.9% over the last year. The company has seen quarterly revenue move from US$155.4 million in Q3 2025 to US$179.6 million in Q3 2026, while quarterly EPS shifted from US$7.54 to US$12.28 over the same period. This sets up a results season in...

Latest FY 2026 earnings snapshot Mesa Laboratories (MLAB) just closed FY 2026 with fourth quarter revenue of US$63.7 million and a loss per share of US$0.75, as net income excluding extra items came in at a loss of US$4.1 million. Over the past year the company has seen quarterly revenue move from US$62.1 million in FY 2025 Q4 to US$63.7 million in FY 2026 Q4, while quarterly EPS has swung between a loss of US$1.31 and a profit of up to US$0.87. This combination of improving trailing...

Movado Group (MOV) just posted Q1 2027 results with revenue of US$142.4 million and basic EPS of US$0.30, compared with trailing twelve month revenue of US$681.9 million and EPS of US$1.44 that delivered year-over-year earnings growth of 80.4%. Over the last year, revenue has been broadly steady at 0.4% growth while net profit margin moved from 2.7% to 4.7%. This sets up this quarter as part of a wider shift in the earnings profile. For investors, that margin progression, combined with the...

Abercrombie & Fitch (ANF) opened Q1 2027 with revenue of US$1.1b and basic EPS of US$1.49, alongside net income of US$67.1m for the quarter. The company recorded quarterly revenue of US$1.10b in Q1 2026 and US$1.11b in Q1 2027, while basic EPS moved from US$1.63 to US$1.49 over the same period. This presents a picture in which investors are weighing solid top line scale against more mixed per share outcomes. With trailing net margin coming in lower than the prior year in the provided data,...

Semtech (SMTC) opened Q1 2027 with revenue of about US$291 million, basic EPS of roughly US$0.29 and net income of around US$26.6 million, providing a clear snapshot of its latest quarterly performance. The company reported revenue of about US$251.1 million in Q1 2026 and roughly US$291 million in Q1 2027, while basic EPS moved from about US$0.22 to roughly US$0.29 over the same period. This offers investors a direct view of how the top and bottom line compare year on year. Overall, margins...

Wondering if Astec Industries at about US$51 per share is offering fair value right now, or if the recent price puts you at risk of overpaying? The stock is up 4.9% over the last 7 days and 14.4% year to date, although it is down 13.1% over the past month, with a 31.0% return over the last year and 44.0% over three years, while the five-year return shows a decline of 20.8%. Recent headlines around infrastructure spending, construction activity and heavy equipment demand have kept attention...

Insulet (NasdaqGS:PODD) issued a voluntary recall and medical device correction for certain Omnipod insulin Pods due to a manufacturing defect that can cause insulin under delivery. The action affects roughly 7 million Pods globally across the Omnipod 5, DASH, and Eros product lines. Insulet has received multiple reports of serious adverse events, including at least 24 severe cases requiring hospitalization, but no fatalities. The company is replacing affected Pods at no cost and does not...

Corbus Pharmaceuticals reported updated Phase 1/2 data for its Nectin-4 antibody‑drug conjugate CRB-701, showing robust activity and manageable safety in HPV‑driven oropharyngeal and cervical cancers, with plans to present the results at the ASCO 2026 meeting and to launch registrational trials in both indications. An interesting development is the FDA’s broad alignment on registrational trial designs targeting accelerated approval in second‑line oropharyngeal squamous cell carcinoma and...